Cabaletta Bio (CABA)
Develops engineered T-cell therapies for autoimmune disease, prioritizing rese-cel.
$2.50
After hours+0.00 (+0.20%)
At close$2.50(+1.42%)
Something off on this page? Send us feedback.
Next report
Nov 9, 26
estimated · in 48 days
EPS estimate
−$0.33
Revenue estimate
$1.7M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.65−$0.71−$0.73−$0.44−$0.40−$0.39−$0.34Pending
Estimate−$0.65−$0.67−$0.71−$0.49−$0.45−$0.41−$0.37−$0.33
Surprise0.0%−6.0%−2.8%+10.2%+11.1%+4.9%+8.8%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$1.6M——————Pending
Estimate——$4.2M—$833.3K$1.7M$1.7M$1.7M
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.29 | — | — |
| Sep 2027 | −$0.30 | — | — |
| Jun 2027 | −$0.30 | — | — |
| Mar 2027 | −$0.29 | — | — |
| Dec 2026 | −$0.32 | — | — |
| Nov 2026 | −$0.33 | — | — |
| Aug 2026 | −$0.37 | −$0.34 | +8.8% |
| May 2026 | −$0.41 | −$0.39 | +4.9% |
| Mar 2026 | −$0.45 | −$0.40 | +11.1% |
| Nov 2025 | −$0.49 | −$0.44 | +10.2% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Dec 2019 | |||
| Jun 2019 | |||
| Mar 2019 | |||
| Dec 2018 | |||
| Sep 2018 | |||
| Jun 2018 | |||
| Mar 2018 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.29 | — | — | $0 | — | — | — |
| Sep 2027 | −$0.30 | — | — | $0 | — | — | — |
| Jun 2027 | −$0.30 | — | — | $0 | — | — | — |
| Mar 2027 | −$0.29 | — | — | $0 | — | — | — |
| Dec 2026 | −$0.32 | — | — | $1.7M | — | — | — |
| Nov 9, 2026 | −$0.33 | — | — | $1.7M | — | — | — |
| Aug 13, 2026 | −$0.37 | −$0.34 | +8.8% | $1.7M | — | — | −4.9% |
| May 14, 2026 | −$0.41 | −$0.39 | +4.9% | $1.7M | — | — | +0.6% |
| Mar 23, 2026 | −$0.45 | −$0.40 | +11.1% | $833.3K | — | — | −4.1% |
| Nov 10, 2025 | −$0.49 | −$0.44 | +10.2% | — | — | — | −4.7% |
| Aug 7, 2025 | |||||||
| May 15, 2025 | |||||||
| Mar 31, 2025 | |||||||
| Nov 14, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 15, 2024 | |||||||
| Mar 21, 2024 | |||||||
| Nov 9, 2023 | |||||||
| Aug 10, 2023 | |||||||
| May 11, 2023 | |||||||
| Mar 16, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Aug 11, 2022 | |||||||
| May 12, 2022 | |||||||
| Mar 17, 2022 | |||||||
| Nov 1, 2021 | |||||||
| Aug 5, 2021 | |||||||
| May 3, 2021 | |||||||
| Mar 16, 2021 | |||||||
| Nov 10, 2020 | |||||||
| Aug 6, 2020 | |||||||
| May 12, 2020 | |||||||
| Mar 30, 2020 | |||||||
| Dec 5, 2019 | |||||||
| Jun 30, 2019 | |||||||
| Mar 31, 2019 | |||||||
| Dec 31, 2018 | |||||||
| Sep 30, 2018 | |||||||
| Jun 30, 2018 | |||||||
| Mar 31, 2018 |